BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 7509909)

  • 1. NG-monomethyl-L-ARG reduces the forearm vasodilator response to acetylcholine but not to methacholine in humans.
    Rongen GA; Smits P; Thien T
    J Cardiovasc Pharmacol; 1993 Dec; 22(6):884-8. PubMed ID: 7509909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is nitric oxide involved in cutaneous vasodilation during body heating in humans?
    Dietz NM; Rivera JM; Warner DO; Joyner MJ
    J Appl Physiol (1985); 1994 May; 76(5):2047-53. PubMed ID: 7520431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cholinergic vasodilator responses to acetylcholine and methacholine in the human forearm.
    Bruning TA; Chang PC; Kemme MJ; Vermeij P; Pfaffendorf M; van Zwieten PA
    Blood Press; 1996 Nov; 5(6):333-41. PubMed ID: 8973750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition by NG-monomethyl-L-arginine of vasodilator effects of acetylcholine and methacholine in human forearm vasculature.
    Chowienczyk PJ; Cockcroft JR; Ritter JM
    Br J Pharmacol; 1993 Oct; 110(2):736-8. PubMed ID: 8242245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans.
    Smits P; Williams SB; Lipson DE; Banitt P; Rongen GA; Creager MA
    Circulation; 1995 Oct; 92(8):2135-41. PubMed ID: 7554193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation.
    Gilligan DM; Panza JA; Kilcoyne CM; Waclawiw MA; Casino PR; Quyyumi AA
    Circulation; 1994 Dec; 90(6):2853-8. PubMed ID: 7994830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of acetylcholinesterase selectively potentiates NG-monomethyl-L-arginine-resistant actions of acetylcholine in human forearm vasculature.
    Chowienczyk PJ; Cockcroft JR; Ritter JM
    Clin Sci (Lond); 1995 Jan; 88(1):111-7. PubMed ID: 7704991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension.
    Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A
    Hypertension; 1997 Jan; 29(1 Pt 2):274-9. PubMed ID: 9039114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandins are involved in acetylcholine- and 5-hydroxytryptamine-induced, nitric oxide-mediated vasodilatation in human forearm.
    Kamper AM; Paul LC; Blauw GJ
    J Cardiovasc Pharmacol; 2002 Dec; 40(6):922-9. PubMed ID: 12451326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of NG-monomethyl-L-arginine on kinin-induced vasodilation in the human forearm.
    Cockcroft JR; Chowienczyk PJ; Brett SE; Ritter JM
    Br J Clin Pharmacol; 1994 Oct; 38(4):307-10. PubMed ID: 7530473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic vasodilation in the human forearm is preserved in hypercholesterolemia despite impairment of endothelium-dependent and independent vasodilation.
    Duffy SJ; New G; Harper RW; Meredith IT
    Cardiovasc Res; 1999 Aug; 43(3):721-30. PubMed ID: 10690343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of nitric oxide in exercise-induced vasodilation of the forearm.
    Endo T; Imaizumi T; Tagawa T; Shiramoto M; Ando S; Takeshita A
    Circulation; 1994 Dec; 90(6):2886-90. PubMed ID: 7994834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does lipoprotein(a) impair endothelial function?
    Schlaich MP; John S; Langenfeld MR; Lackner KJ; Schmitz G; Schmieder RE
    J Am Coll Cardiol; 1998 Feb; 31(2):359-65. PubMed ID: 9462580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nitric oxide in reactive hyperemia in human forearm vessels.
    Tagawa T; Imaizumi T; Endo T; Shiramoto M; Harasawa Y; Takeshita A
    Circulation; 1994 Nov; 90(5):2285-90. PubMed ID: 7955185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Adrenoceptor-mediated, nitric-oxide-dependent vasodilatation is abnormal in early hypertension: restoration by L-arginine.
    Schlaich MP; Ahlers BA; Parnell MM; Kaye DM
    J Hypertens; 2004 Oct; 22(10):1917-25. PubMed ID: 15361763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of ATP-induced vasodilation in the human forearm vascular bed.
    Rongen GA; Smits P; Thien T
    Circulation; 1994 Oct; 90(4):1891-8. PubMed ID: 7923677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of nitric oxide to exercise hyperemia in the human forearm.
    Gordon MB; Jain R; Beckman JA; Creager MA
    Vasc Med; 2002 Aug; 7(3):163-8. PubMed ID: 12553738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin-induced vasodilatation in the human forearm is mediated by the "nitric oxide-pathway": no evidence for involvement of the 5-HT3-receptor.
    Bruning TA; Chang PC; Blauw GJ; Vermeij P; van Zwieten PA
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):44-51. PubMed ID: 7690095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension.
    Taddei S; Virdis A; Ghiadoni L; Magagna A; Favilla S; Pompella A; Salvetti A
    Hypertension; 2001 Mar; 37(3):943-8. PubMed ID: 11244022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forearm blood flow responses to a nitric oxide synthase inhibitor in patients with treated essential hypertension.
    Calver A; Collier J; Vallance P
    Cardiovasc Res; 1994 Nov; 28(11):1720-5. PubMed ID: 7531114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.